| Urinary and Genital Oncology Studies | Lifetime | 54 | IT 3 | 99.50 |
| Bladder and Urothelial Cancer Treatments | Lifetime | 100 | IT 4 | 99.46 |
| Cancer Immunotherapy and Biomarkers | Lifetime | 299 | IT 11 | 99.27 |
| Genital Health and Disease | Lifetime | 87 | IT 4 | 98.98 |
| Testicular diseases and treatments | Lifetime | 78 | IT 4 | 98.82 |
| Urological Disorders and Treatments | Lifetime | 236 | IT 8 | 98.85 |
| Urologic and reproductive health conditions | Lifetime | 144 | IT 11 | 99.05 |
| Renal cell carcinoma treatment | Lifetime | 418 | IT 31 | 98.12 |
| Multiple and Secondary Primary Cancers | Lifetime | 221 | IT 22 | 97.65 |
| Colorectal and Anal Carcinomas | Lifetime | 477 | IT 24 | 97.18 |
| Fibroblast Growth Factor Research | Lifetime | 240 | IT 7 | 96.33 |
| Esophageal Cancer Research and Treatment | Lifetime | 616 | IT 19 | 96.92 |
| Sarcoma Diagnosis and Treatment | Lifetime | 999 | IT 78 | 96.90 |
| Neuroblastoma Research and Treatments | Lifetime | 759 | IT 66 | 96.44 |
| Infectious Disease Case Reports and Treatments | Lifetime | 311 | IT 15 | 81.02 |
| Gestational Trophoblastic Disease Studies | Lifetime | 874 | IT 44 | 80.00 |
| Bladder and Urothelial Cancer Treatments | 2021-2025 | 4 | IT 1 | 99.90 |
| Urinary and Genital Oncology Studies | 2021-2025 | 4 | IT 1 | 99.90 |
| Genital Health and Disease | 2021-2025 | 3 | IT 1 | 99.11 |
| Urological Disorders and Treatments | 2021-2025 | 11 | IT 5 | 99.19 |
| Cancer Immunotherapy and Biomarkers | 2021-2025 | 81 | IT 7 | 99.67 |
| Epigenetics and DNA Methylation | 2021-2025 | 54 | IT 1 | 98.47 |
| Urologic and reproductive health conditions | 2021-2025 | 10 | IT 4 | 98.41 |
| Fibroblast Growth Factor Research | 2021-2025 | 12 | IT 1 | 98.26 |
| Esophageal Cancer Research and Treatment | 2021-2025 | 133 | IT 4 | 96.82 |
| Multiple and Secondary Primary Cancers | 2021-2025 | 44 | IT 1 | 94.28 |
| Cancer Research and Treatments | 2021-2025 | 90 | IT 1 | 94.58 |
| Renal cell carcinoma treatment | 2021-2025 | 181 | IT 39 | 96.97 |
| Colorectal and Anal Carcinomas | 2021-2025 | 120 | IT 14 | 95.99 |
| Cancer Diagnosis and Treatment | 2021-2025 | 240 | IT 21 | 87.77 |
| Prostate Cancer Treatment and Research | 2021-2025 | 847 | IT 74 | 92.98 |
| Colorectal Cancer Screening and Detection | 2021-2025 | 843 | IT 44 | 89.81 |
| Genetic factors in colorectal cancer | 2021-2025 | 855 | IT 94 | 87.24 |
| Testicular diseases and treatments | 2021-2025 | 242 | IT 20 | 81.91 |
| Infectious Disease Case Reports and Treatments | 2021-2025 | 65 | IT 11 | 66.65 |
| Female Genital Mutilation/Cutting Issues | 2021-2025 | 732 | IT 33 | 32.47 |
| Tuberous Sclerosis Complex Research | 2021-2025 | 838 | IT 51 | 29.24 |
